WallStSmart
TWST

Twist Bioscience Corp

NASDAQ: TWST · HEALTHCARE · DIAGNOSTICS & RESEARCH

$56.70
-4.14% today

Updated 2026-04-29

Market cap
$3.48B
P/E ratio
P/S ratio
8.88x
EPS (TTM)
$-1.27
Dividend yield
52W range
$23 – $66
Volume
1.2M

Twist Bioscience Corp (TWST) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-1.6%
Last 4 quarters
Revenue YoY growth
+16.9%
Most recent quarter
EPS YoY growth
+5.7%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-2.9%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-18.3%
2025-08-04
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-02$-0.50-16.3%$41.07$46.32+12.8%
2025-11-17$-0.45+10.0%$26.87$26.00-3.2%
2025-08-04$-0.47+17.5%$33.68$27.52-18.3%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.43$-0.50-16.3%$103.70M+16.9%
2025-09-30$-0.50$-0.45+10.0%$99.01M+16.9%
2025-06-30$-0.57$-0.47+17.5%$96.06M+17.9%
2025-03-31$-0.56$-0.66-17.9%$92.79M+23.2%
2024-12-31$-0.63$-0.53+15.9%$88.71M+24.1%
2024-09-30$-0.70$-0.59+15.7%$84.71M+26.5%
2024-06-30$-0.77$-1.47-90.9%$81.46M+27.8%
2024-03-31$-0.82$-0.79+3.7%$75.30M
2023-12-31$-0.78$-0.75+3.8%$71.50M
2023-09-30$-0.92$-0.81+12.0%$66.95M
2023-06-30$-1.14$-0.78+31.6%$63.74M

Frequently asked questions

Has Twist Bioscience Corp beaten earnings estimates?
Twist Bioscience Corp has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -1.6% over the last 4 quarters.
How does TWST stock react to earnings?
TWST stock has moved an average of -2.9% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Twist Bioscience Corp's revenue growth rate?
Twist Bioscience Corp reported year-over-year revenue growth of +16.9% in its most recent quarter, with EPS growing +5.7% year-over-year.